January 25, 2023
Race and geography linked to different risks of breast cancer treatment delays
A study led by Katherine Reeder-Hayes, MD, MBA, MS, found that Black patients and patients living in certain regions experience greater delays.
January 25, 2023
A study led by Katherine Reeder-Hayes, MD, MBA, MS, found that Black patients and patients living in certain regions experience greater delays.
January 25, 2023
Shawn Hingtgen, PhD, and his lab team have developed a method they call a “slice platform” that may help clinicians choose the best treatment for their brain tumor patients.
October 6, 2022
UNC Lineberger researchers have found a possible way to overcome barriers that block anti-cancer immune responses. Their findings could have implications for treating solid tumors, including breast and pancreatic cancer.
September 27, 2022
Adding detection of immune cell protein SYNGR3 to current protocols could lead to a more reliable way of determining which patients with head and neck cancer need less intensive treatment.
September 13, 2022
UNC Lineberger’s Yuliya Pylayeva-Gupta, PhD, was the corresponding author of a paper published in Cell Reports Medicine that examined how B cells might be reprogrammed to improve anti-tumor immune response in pancreatic cancer. The study was led by a former research associate, Rahul Mirlekar.
August 30, 2022
UNC Lineberger awarded 17 developmental research grants totaling nearly $1.1 million to faculty during the spring 2022 award cycle.
June 5, 2022
Ethan Basch, MD, MSc, FASCO, reports that people with advanced cancer who reported their symptoms weekly using an electronic survey had better outcomes compared to those who were evaluated less frequently via in-person clinical visits.
May 10, 2022
Seth Noar, PhD, Marcella Boynton, PhD, and colleagues report that effective anti-vaping advertisements geared to teens have the greatest impact when they emphasize adverse consequences and harms.
April 26, 2022
A newer, less expensive nanotechnology may make it possible to more accurately diagnose children with acute leukemia in lower income countries, according to findings by Thomas Alexander, MD, MPH, and colleagues.
February 24, 2022
Greg Wang, PhD, and colleagues have uncovered a new role of a chromatin-modulatory enzyme, termed EZH2, during cancer development.